Patient Journey Consulting
- Home
- patient journey
The Importance of Patient Journey Consulting
At DelveInsight, we map the entire patient journey from symptom onset to long-term management to uncover treatment gaps and inform life sciences strategies with insights from KOLs, providers, and patients.
Why Patient Journey Insights Matter in Drug Development?
Identifying Unmet Medical Needs
Patients face delays and misdiagnoses due to limited specialist access and diagnostic gaps. Mapping the patient journey helps biopharma identify barriers and drive innovation to improve treatment access.
Optimizing Drug Development & Clinical Trial Design
A patient-centric approach aligns trial endpoints with real-world needs, enhancing relevance. Decentralized models and clear communication reduce barriers, boosting participation and accelerating drug development.
Enhancing Market Access & Adoption
After approval, patient access and affordability remain major hurdles. Pharma can address these via value-based pricing, patient aid, and prescriber education based on payer and prescriber insights.
20+
Geographic Coverage
Vast opinions
of industry KOLs
Need to transform Global Drug Development with Patient-Centric Insights?
Patient Journey Flow Chart
Country-specific treatment guidelines are foundational to how a healthcare system diagnoses, manages, and treats diseases. Developed by national health authorities, professional medical associations, or payer bodies, these guidelines influence every stage of the patient journey from symptom recognition and diagnosis to treatment access and follow-up care.
Understanding and aligning with these localized guidelines is critical for biopharma companies to develop drugs successfully, enter the market, and commercialize them.
Top Features
Unique Selling Propositions (USPs)
At the forefront of patient journey optimization, we offer a suite of unique selling propositions designed to transform healthcare experiences. Our expertise in patient-centric solutions ensures that we understand the nuances of patient needs, backed by years of industry experience. We harness Data-Driven Insights through advanced analytics, enabling healthcare providers to make informed decisions that enhance patient outcomes.
Deep Industry Expertise
Years of experience in patient journey consulting.
Data-Driven Insights
AI-driven analytics for actionable strategies.
Worldwide Reach
Extensive network of Key Opinion Leaders (KOLs), physicians, and patient advocacy groups.
Customized Solutions
Tailored strategies to meet the unique needs of each client.
Challenges in Patient Journey Mapping Across Countries
Key Solution: Early engagement with market access experts and KOLs to develop region-specific value propositions, ensuring alignment with local reimbursement policies, healthcare infrastructure, and patient access pathways. This includes conducting health economic and outcomes research (HEOR) to demonstrate cost-effectiveness, gathering real-world evidence (RWE) to support clinical and economic value, and tailoring messaging to address the specific needs of payers, providers, and patient advocacy groups. Establishing advisory boards and early stakeholder feedback loops can further refine the value proposition and accelerate market adoption.
How DelveInsight Can Help Overcome These Challenges?
- Global Patient Journey Insights: Region-specific analysis to map country-wise patient challenges.
- KOL & Payer Engagement: Early collaboration with key stakeholders to streamline market entry.
- Reimbursement & Market Access Strategies: Tailored approaches to accelerate pricing approvals and drug adoption.
- Clinical Trial Optimization: Patient-centric strategies to enhance trial recruitment and retention.
- Regulatory & Compliance Expertise: Guidance on navigating country-specific regulatory landscapes.
Key Challenges
Variations in Healthcare Systems
Key Insight:
A one-size-fits-all approach doesn’t work—drug developers must adapt strategies to each region’s healthcare landscape.
Premium Insights
Healthcare Blogs
Get comprehensive insights into the healthcare industry and epidemiology-based market forecasts with a 360° panoramic picture of the market alongside the latest trends, developments, and future opportunities.
Subscribe to our Updates
Receive recent Healthcare updates directly in your inbox.
DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.
Therapeutic Access in Rare Diseases and Oncology
Zolgensma’s Pricing Challenges in Different Markets
Novartis’ ZOLGENSMA encountered vastly different reimbursement and pricing scenarios across countries due to variations in healthcare systems, regulatory frameworks, and economic conditions.
India
Japan
United Kingdom
Germany
United States
Key Benefits of Our Patient Journey Consulting
- Identify Gaps in Care and Unmet Patient Needs: Pinpoint areas where patient needs are not being met to improve care delivery.
- Enhance Patient Engagement Strategies: Develop targeted strategies to improve patient involvement and satisfaction.
- Optimize Market Access and Brand Positioning: Align products and services with patient needs to improve market performance.
- Improve Healthcare Provider-Patient Interactions: Facilitate better communication and understanding between providers and patients.
- Strengthen Health Economics and Outcomes Research (HEOR): Leverage real-world evidence to demonstrate value and inform decision-making.
Global Disparities in Treatment Guidelines
Global disparities in treatment guidelines present a significant challenge for patients navigating their healthcare journeys. These disparities arise due to variations in healthcare infrastructure, regulatory approvals, access to medical technologies, and the availability of clinical data across countries. While some regions benefit from cutting-edge treatments and well-established clinical protocols, others rely on outdated guidelines or face limited access to life-saving therapies.
On the other hand, these guidelines offer strategic opportunities for companies launching new drugs by highlighting unmet medical needs, especially in low- and middle-income countries. These variations, along with differences in insurance coverage and reimbursement, can guide tailored market entry, pricing, and access strategies. By addressing these gaps, companies can expand their reach while contributing to global health equity.
Treatment Standards Based on Last Update
A total of 46 cervical cancer treatment guidelines were identified. Most were last updated between 2016 and 2021 (33/46 [72%]), with the oldest guideline developed in 2010.
Region-Wise Therapeutic Guideline
The 46 included guidelines represent 3 global health organizations, 5 pan-European organizations, 1 continental subregion, and 22 individual countries across 6 geographic regions.
Cross-Country Treatment Guideline Adoption
The country-specific and regional clinical guidelines highlight differences in healthcare practices worldwide, along with the importance of tailored patient journeys based on local standards.
Case Studies
Enhancing the Hypertension Patient Journey
Explore how a leading pharmaceutical company sought to deepen its understanding of the hypertension patient journey across multiple markets: the US, UK, Japan, Switzerland, Italy, and France.
View Case StudyKOL Profiling
Discover how engaging with top KOLs strengthened the client' pharma leadership
View Case StudyDigital Opinion Leader Analysis
Find out how the client gained market and stakeholder insights from digital cystic fibrosis analysis
View Case StudyCutaneous Squamous Cell Carcinoma Epidemiology Insight
Discover how we assisted a US client in evaluating the epidemiology of cSCC in solid organ transplant recipients across 15 countries.
View Case StudyGet Expert Consultation Now!
